| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 288.27a | 453.93a |
| Accounts receivable, net | 473.58a | 457.45a |
| Inventories | 381.88a | 380.28a |
| Other current assets | 256.18a | 203.6a |
| Total current assets | 1,399.9a | 1,495.25a |
| Long-term assets | — | — |
| Property and equipment, net | 713.12a | 702.18a |
| Operating lease right-of-use assets | 116.13a | 115.5a |
| Goodwill | 405.1a | 365.96a |
| Intangible assets, net | 111.68a | 84.5a |
| Other long-term assets | 547.52a | 496.53a |
| Total long-term assets | 1,893.55a | 1,764.67a |
| Total assets | 3,293.44a | 3,259.93a |
| Liabilities and stockholders’ equity | — | — |
| Current liabilities | — | — |
| Accounts payable | 114.21a | 110.64a |
| Accrued liabilities | 502.12a | 478.71a |
| Credit facility | 250a | 250a |
| Current portion of long-term debt | 167.79a | 75a |
| Current portion of deferred revenue | 33.8a | 37.2a |
| Total current liabilities | 1,067.92a | 951.55a |
| Long-term liabilities | — | — |
| Deferred income tax liabilities | 11.31a | 7.24a |
| Long-term debt, net of current portion | 449.79a | 622.88a |
| Long-term deferred revenue, net of current portion | 26.94a | 28.53a |
| Long-term operating lease liabilities, net of current portion | 97.84a | 99.67a |
| Other long-term liabilities | 44.34a | 65.53a |
| Total long-term liabilities | 630.21a | 823.85a |
| Total liabilities | 1,698.13a | 1,775.4a |
| Stockholders’ equity | — | — |
| Common stock | 10.78a | 10.75a |
| Additional paid-in capital | 1,673.86a | 1,569.57a |
| Deferred stock units | 5.89a | 5.53a |
| Retained earnings | 5,332.44a | 4,444.57a |
| Accumulated other comprehensive loss | -93.65a | -71.21a |
| Treasury stock, at cost | -5,334.01a | -4,474.68a |
| Total IDEXX Laboratories, Inc. stockholders’ equity | 1,595.31a | 1,484.53a |
| Total liabilities and stockholders’ equity | 3,293.44a | 3,259.93a |